Medpace Holdings Inc (MEDP) — Capital Reinvestment Ratio
Latest as of March 2026:
0.04x
Medpace Holdings Inc (MEDP) has a Capital Reinvestment Ratio of 0.04x as of March 2026, meaning it reinvests 0% of its operating cash flow ($151.79 Million) in capital expenditures ($6.81 Million). See cash generation quality of Medpace Holdings Inc to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
0.04x
Capex / Operating Cash Flow
Operating Cash Flow
$151.79 Million
USD
Capital Expenditures
$6.81 Million
USD
Data as of
Mar 2026
Most recent filing
Medpace Holdings Inc Capital Reinvestment Ratio (2013–2025)
This chart tracks Medpace Holdings Inc's Capital Reinvestment Ratio across 13 annual periods.
Annual Capital Reinvestment Ratio for Medpace Holdings Inc (2013–2025)
Year-by-year Capital Reinvestment Ratio for Medpace Holdings Inc from 2013 to 2025. For live market cap and broader valuation context, see MEDP market cap overview.
| Year | Reinvestment Ratio | Operating CF (USD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.04x | $713.22 Million | $31.36 Million | ▼ -26.8% |
| 2024 | 0.06x | $608.82 Million | $36.55 Million | ▼ -29.0% |
| 2023 | 0.08x | $433.37 Million | $36.65 Million | ▼ -11.0% |
| 2022 | 0.10x | $388.05 Million | $36.88 Million | ▼ -11.5% |
| 2021 | 0.11x | $263.33 Million | $28.27 Million | ▼ -11.4% |
| 2020 | 0.12x | $258.68 Million | $31.34 Million | ▲ +36.5% |
| 2019 | 0.09x | $201.87 Million | $17.91 Million | ▼ -13.3% |
| 2018 | 0.10x | $156.58 Million | $16.02 Million | ▼ -18.9% |
| 2017 | 0.13x | $97.39 Million | $12.29 Million | ▼ -14.5% |
| 2016 | 0.15x | $91.73 Million | $13.54 Million | ▲ +96.0% |
| 2015 | 0.08x | $85.87 Million | $6.46 Million | ▲ +6.5% |
| 2014 | 0.07x | $75.20 Million | $5.32 Million | ▲ +52.1% |
| 2013 | 0.05x | $98.14 Million | $4.56 Million | — |
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow